Filing Flows › GoodRx Holdings (GDRX) › Q2 2026
GoodRx Holdings (GDRX) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 5, 2026
GoodRx Holdings (GDRX) reported revenue of $200M for the second quarter 2026 (Q2 2026), -1% from a year earlier and +3% from the quarter before. Operating margin was 11.8%, net earnings $8.5M (4.3% of revenue).
GoodRx Holdings, Q2 2026: revenue $200M (-1% year over year), operating margin 11.8%, net earnings $8.5M, operating cash flow $80.8M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $200M | +3% | -1% |
| Operating profit | $23.6M | +69% | -12% |
| Net earnings | $8.5M | +630% | -34% |
| Operating cash flow | $80.8M | +583% | +63% |
| Free cash flow | $80.5M | +652% | +64% |
What changed
Revenue was $200.4M in Q2 2026, down 1% year over year and up 3% from the previous quarter. Prescription transactions revenue was the largest line at 53% of revenue. Prescription transactions revenue lost $36.7M year over year (down 26%), 1379% of the total change.
Operating profit was $23.6M, a 11.8% margin (down 1.4 points year over year). Total costs grew 0% against a revenue fall of 1%. The fastest-growing cost line was Cost of revenue (+57%). Net earnings were $8.5M, down 34% year over year. The effective tax rate was 44.8%.
Operating cash flow was $80.8M (up 63% year over year), 947% of net earnings. Non-cash charges added back $22.3M of depreciation and amortization and $16.6M of share-based compensation. Working capital and other items added $33.4M. Capital expenditures of $362K left free cash flow of $80.5M.
Questions
What was GoodRx Holdings' revenue in the second quarter 2026?
GoodRx Holdings (GDRX) reported revenue of $200M for the second quarter 2026 (Q2 2026), -1% from a year earlier and +3% from the quarter before.
Was GoodRx Holdings profitable in the second quarter 2026?
Operating profit was $23.6M (11.8% of revenue) and net earnings $8.5M.
Source: GoodRx Holdings 10-Q on SEC EDGAR.